- Report
- August 2026
- 177 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- April 2026
- 144 Pages
Global
From €2688EUR$2,999USD£2,306GBP
€3584EUR$3,999USD£3,075GBP
- Report
- April 2026
- 137 Pages
Global
From €2688EUR$2,999USD£2,306GBP
€3584EUR$3,999USD£3,075GBP
- Report
- April 2026
- 138 Pages
Global
From €2688EUR$2,999USD£2,306GBP
€3584EUR$3,999USD£3,075GBP
- Report
- March 2026
- 138 Pages
Global
From €2688EUR$2,999USD£2,306GBP
€3584EUR$3,999USD£3,075GBP
- Report
- March 2026
- 135 Pages
Global
From €2688EUR$2,999USD£2,306GBP
€3584EUR$3,999USD£3,075GBP
- Report
- May 2026
- 130 Pages
Global
From €5332EUR$5,950USD£4,575GBP
- Report
- January 2026
- 175 Pages
Global
From €5332EUR$5,950USD£4,575GBP
- Report
- June 2026
- 140 Pages
Global
From €5332EUR$5,950USD£4,575GBP
- Report
- April 2026
- 139 Pages
Global
From €2688EUR$2,999USD£2,306GBP
€3584EUR$3,999USD£3,075GBP
- Report
- August 2026
- 372 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- January 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- August 2026
- 162 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 409 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- June 2026
- 196 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP
- Report
- January 2026
- 197 Pages
Global
From €3177EUR$3,545USD£2,726GBP
€3530EUR$3,939USD£3,029GBP

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision.
Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more